Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
FLIP1Q7Z7B0Filamin-A-interacting protein 1 (FILIP)Predicted intracellular proteinsReceptor-signaling mediation30.38
GBB3P16520Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3)Disease related genesHuman disease related genesPlasma proteinsClinical-translation mediationFusion and delivery mediationImmune mediation30.38
GRDNQ3V6T2Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1)Disease related genesHuman disease related genesPredicted intracellular proteinsFusion and delivery mediationReceptor-signaling mediation30.38
I11RAQ14626Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)]Disease related genesFDA approved drug targetsHuman disease related genes1Prostate cancerThrombocytopeniaClinical-translation mediationFusion and delivery mediationImmune mediation30.38
LMOD2Q6P5Q4Leiomodin-2 (Cardiac leiomodin) (C-LMOD) (Leiomodin)Disease related genesPredicted intracellular proteinsFusion and delivery mediation30.38
METP08581Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)Cancer-related genesDisease related genesEnzymes1Alzheimer diseaseBiliary tract cancerBrain cancerClinical-translation mediationFusion and delivery mediationImmune mediation30.38
NCKPLP55160Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)Disease related genesHuman disease related genesPlasma proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation30.38
NTNG2Q96CW9Netrin-G2 (Laminet-2)Disease related genesHuman disease related genesPredicted intracellular proteinsAdhesion and uptake mediationMetabolism mediation30.38
NTRK2Q16620BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B)Cancer-related genesDisease related genesEnzymes1Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation30.38
PECA1P16284Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31)Cancer-related genesCandidate cardiovascular disease genesCD markers1Adhesion and uptake mediationFusion and delivery mediationImmune mediation30.38
T23OP48775Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)Disease related genesEnzymesHuman disease related genesClinical-translation mediationMetabolism mediation30.38
ACHA5P30532Neuronal acetylcholine receptor subunit alpha-5FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins4Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.38
AFADP55196Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor)Cancer-related genesDisease related genesPlasma proteinsAdhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation20.38
ANXA3P12429Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)FDA approved drug targetsMetabolic proteinsPlasma proteinsClinical-translation mediationFusion and delivery mediationImmune mediation20.38
CANB2Q96LZ3Calcineurin subunit B type 2 (Calcineurin B-like protein) (CBLP) (Calcineurin BII) (CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform)FDA approved drug targetsPredicted intracellular proteinsClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.38
CCBE1Q6UXH8Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog)Disease related genesHuman disease related genesPlasma proteinsMetabolism mediationReceptor-signaling mediation20.38
CD8AP01732T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a)CD markersDisease related genesHuman disease related genes1Fusion and delivery mediationImmune mediation20.38
CF418Q96NL8Cilia- and flagella-associated protein 418Disease related genesHuman disease related genesPredicted intracellular proteinsOther mediation20.38
CRKP46108Adapter molecule crk (Proto-oncogene c-Crk) (p38)Predicted intracellular proteinsAdhesion and uptake mediationClinical-translation mediationImmune mediation20.38
CTND1O60716Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas))Cancer-related genesDisease related genesHuman disease related genesClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.38
EFHC1Q5JVL4EF-hand domain-containing protein 1 (Myoclonin-1)Disease related genesHuman disease related genesPredicted intracellular proteinsOther mediation20.38
ENOBP13929Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)Candidate cardiovascular disease genesDisease related genesEnzymesMetabolism mediation20.38
ENOGP09104Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)Cancer-related genesCandidate cardiovascular disease genesEnzymesMetabolism mediation20.38
FASP49327Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]Cancer-related genesEnzymesMetabolic proteinsBrain cancerColon cancerconcerning food/fluid intake symptomClinical-translation mediationImmune mediationMetabolism mediation20.38
FHITP49789Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)Cancer-related genesDisease related genesEnzymesNausea/vomitingClinical-translation mediation20.38

476-500 of 792 proteins

Page